Although high ALCAM expression levels have been associated with better outcome and might be predictive for chemotherapy response in breast cancer, the underlying biological mechanism for survival benefit still remains unclear (King et al, 2004; Ihnen et al, 2008). The gene discussed is ALCAM; the disease is breast cancer.